Literature DB >> 12021921

Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays.

Karl-Ludwig Schaefer1, Daniel H Wai, Christopher Poremba, Eberhard Korsching, Frans van Valen, Toshifumi Ozaki, Werner Boecker, Barbara Dockhorn-Dworniczak.   

Abstract

GG-62 is a cell line previously thought to be derived from an atypical Ewing tumor (ET). Reverse-transcriptase polymerase chain reaction revealed an in-frame fusion between the Ewing sarcoma gene ( EWS) codon 325 and the activating transcription factor 1 gene ( ATF1) codon 65 which permits the production of chimeric EWS-ATF1 oncoproteins. We also identified the genomic breakpoint resulting from a reciprocal t(12;22)(q13;q12), which is the hallmark of malignant melanoma of soft parts (MMSP). We applied Affymetrix human cancer G110 arrays to compare the gene expression patterns of GG-62 and other cell lines derived from small blue round cell tumors of childhood. Hierarchical clustering of 463 differentially expressed genes distinguished GG-62 from the ETs, as well as the neuroblastomas, and revealed a cluster of 36 upregulated genes. Several of these genes are involved in signal transduction pathways that may be critical for maintaining cell transformation; some examples are avian erythroblastic leukemia viral oncogene homolog 3 ( ERBB3), neuregulin 1 ( NRG1), fibroblast growth factor 9 ( FGF9), and fibroblast growth factor receptor-1 ( FGFR1). Furthermore, genes near the chromosome-12q13 breakpoint exhibited increased expression of GG-62 including ERBB3, NR4A1 (nuclear receptor subfamily 4, group A, member 1), cyclin-dependent kinase 2 ( CDK2), and alpha 5 integrin ( ITGA5). Altogether our findings demonstrate the MMSP derivation of GG-62 and may shed light on the mechanisms of tumorigenesis in this rare disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12021921     DOI: 10.1007/s00428-001-0558-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  10 in total

1.  Constitutive activation of neuregulin/ERBB3 signaling pathway in clear cell sarcoma of soft tissue.

Authors:  Karl-Ludwig Schaefer; Kristin Brachwitz; Yvonne Braun; Raihanatou Diallo; Daniel H Wai; Susanne Zahn; Dominik T Schneider; Cornelius Kuhnen; Arabel Vollmann; Gero Brockhoff; Helmut E Gabbert; Christopher Poremba
Journal:  Neoplasia       Date:  2006-07       Impact factor: 5.715

Review 2.  Roles for neuregulins in human cancer.

Authors:  Christophe Stove; Marc Bracke
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 3.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

4.  Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines.

Authors:  Marimu Sakumoto; Rieko Oyama; Mami Takahashi; Yoko Takai; Fusako Kito; Kumiko Shiozawa; Zhiwei Qiao; Makoto Endo; Akihiko Yoshida; Akira Kawai; Tadashi Kondo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-12-01       Impact factor: 2.416

5.  Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma.

Authors:  Yuchun Luo; Steven Robinson; Junichi Fujita; Lisa Siconolfi; Jay Magidson; Carl K Edwards; Karl Wassmann; Kathleen Storm; David A Norris; Danute Bankaitis-Davis; William A Robinson; Mayumi Fujita
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

6.  Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks.

Authors:  Heiko Fensterer; Bernhard Radlwimmer; Jörn Sträter; Malte Buchholz; Daniela E Aust; Catherine Julié; François Radvanyi; Bernard Nordlinger; Claudio Belluco; Eric Van Cutsem; Claus-Henning Köhne; Hans A Kestler; Carsten Schwaenen; Michelle Nessling; Manfred P Lutz; Peter Lichter; Thomas M Gress
Journal:  BMC Cancer       Date:  2007-04-02       Impact factor: 4.430

7.  Pedican: an online gene resource for pediatric cancers with literature evidence.

Authors:  Min Zhao; Lei Ma; Yining Liu; Hong Qu
Journal:  Sci Rep       Date:  2015-06-15       Impact factor: 4.379

8.  ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma.

Authors:  Chongchang Zhou; Yiming Shen; Zhengyu Wei; Zhisen Shen; Ming Tang; Yi Shen; Hongxia Deng
Journal:  J Clin Lab Anal       Date:  2022-01-07       Impact factor: 2.352

9.  The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma.

Authors:  K K C Li; J Goodall; C R Goding; S-K Liao; C-H Wang; Y-C Lin; H Hiraga; T Nojima; K Nagashima; K-L Schaefer; K A W Lee
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

10.  Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS.

Authors:  Hidetatsu Outani; Takaaki Tanaka; Toru Wakamatsu; Yoshinori Imura; Kenichiro Hamada; Nobuhito Araki; Kazuyuki Itoh; Hideki Yoshikawa; Norifumi Naka
Journal:  BMC Cancer       Date:  2014-06-19       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.